PHIO PHARMACEUTICALS CORP. Common Stock, Capital Shares Reserved for Future Issuance
PHIO PHARMACEUTICALS CORP. (PHIO) had Common Stock, Capital Shares Reserved for Future Issuance of 801.36 million shares as of 2012-12-31, per its 10-K filed 2013-03-29.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2013-03-29
- 2012-12-31: Common Stock, Capital Shares Reserved for Future Issuance 801.36M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2012-12-31 | 801.36M shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |